This protocol is judged by an institutional review board, an independent group that reviews any medical trials involving humans. If a examine involves a Agenda I drug, as soon as the board approves the protocol as ethical, the researchers have to apply for an investigational new drug (IND) selection within the FDA.And since the copyright goes over